Figure 3From: Prognostic role of serum p53 antibodies in lung cancerSurvival curves of NSCLC patients with p53Ab-positive or p53Ab-low/negative- serum. Survival curves of NSCLC patients with p53Ab-positive-serum (dotted line, nā=ā36) or p53Ab-low/negative-serum (unbroken line, nā=ā152). Patients with p53Ab-low/negative-serum had a significantly longer overall survival than those with p53Ab-positive-serum (pā=ā0.049).Back to article page